| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.0B | $13.0B | $12.2B | $14.9B | $14.0B | $3.0B | $2.8B | $10.4B |
| Cost of Revenue | $9.9B | $9.4B | $8.8B | $10.5B | $9.0B | $8.3B | $8.2B | $7.0B |
| Gross Profit | $4.0B | $3.6B | $3.4B | $4.4B | $5.0B | $0.8B | $0.8B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.2B | $2.2B | $2.0B | $2.0B | $1.7B | $1.6B | $1.6B | $1.8B |
| Operating Income | $1.4B | $1.1B | $0.7B | $1.8B | $2.4B | $0.3B | $0.3B | $1.4B |
| Net Income | $0.9B | $0.7B | $0.4B | $1.3B | $1.6B | $0.2B | $0.2B | $0.7B |
| EPS (Basic) | $10.54 | $8.89 | $4.80 | $14.05 | $15.99 | $2.34 | $1.58 | $6.91 |
| EPS (Diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $15.88 | $2.32 | $1.56 | $6.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.4B | $18.4B | $16.7B | $20.2B | $20.1B | $18.0B | $16.2B | $16.6B |
| Current Assets | $4.0B | $4.8B | $3.8B | $4.6B | $5.1B | $3.0B | $2.8B | $2.7B |
| Cash & Equivalents | $0.5B | $1.5B | $0.5B | $0.4B | $1.3B | $0.3B | $0.4B | $0.3B |
| Total Liabilities | $9.8B | $10.3B | $8.8B | $10.0B | $10.7B | $10.5B | $9.2B | $9.7B |
| Current Liabilities | $2.8B | $3.3B | $3.2B | $3.1B | $3.1B | $2.7B | $1.9B | $2.0B |
| Stockholders' Equity | $8.6B | $8.1B | $7.9B | $10.1B | $9.4B | $7.6B | $7.0B | $6.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.6B | $1.3B | $2.0B | $2.1B | $1.4B | $1.3B | $1.5B |
| Investing Cash Flow | $-1.2B | $-1.4B | $-1.2B | $-1.7B | $-0.6B | $-1.3B | $0.2B | $-2.2B |
| Capital Expenditures | $0.4B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B |
| Financing Cash Flow | $-1.5B | $0.8B | $-0.1B | $-1.3B | $-0.5B | $-0.3B | $-1.4B | $0.6B |